↓ Skip to main content

A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

Overview of attention for article published in Frontiers in oncology, May 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
3 news outlets
twitter
162 X users
facebook
1 Facebook page
reddit
1 Redditor
video
1 YouTube creator

Readers on

mendeley
117 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas
Published in
Frontiers in oncology, May 2021
DOI 10.3389/fonc.2021.649555
Pubmed ID
Authors

Janet Schloss, Judith Lacey, Justin Sinclair, Amie Steel, Michael Sughrue, David Sibbritt, Charles Teo

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 162 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 117 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 10%
Student > Master 11 9%
Researcher 10 9%
Student > Ph. D. Student 9 8%
Other 5 4%
Other 15 13%
Unknown 55 47%
Readers by discipline Count As %
Medicine and Dentistry 22 19%
Nursing and Health Professions 7 6%
Neuroscience 7 6%
Biochemistry, Genetics and Molecular Biology 5 4%
Psychology 4 3%
Other 12 10%
Unknown 60 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 126. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2024.
All research outputs
#357,552
of 26,483,923 outputs
Outputs from Frontiers in oncology
#58
of 23,469 outputs
Outputs of similar age
#9,830
of 464,153 outputs
Outputs of similar age from Frontiers in oncology
#2
of 1,329 outputs
Altmetric has tracked 26,483,923 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 23,469 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 464,153 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 1,329 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.